Alternative data datasets
Browse by provider, category, marketplace, access, delivery and license
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
Application that assesses whether patients meet the criteria to participate in a clinical trial.
Clinical Trial Automation Suite.
A contact file covering approximately four million US nurses and nurse practitioners, featuring confirmed email addresses and phone numbers, updated four times a year.
A database of around four million US nurses and nurse practitioners, including their specialties, credentials, employers, and mailing addresses, refreshed on a quarterly basis.
Measures of compliance and therapeutic groupings for the U.S. prescription drug market.
Full U.S. prescription sales data alongside drug details and demographic information.
A subscription-based offering provides hosted access to the MarketScan Research Databases, delivering analytics and insights on healthcare claims, encounters, and related data for research purposes.
An analysis-ready compilation of roughly 3,000 ClinicalTrials.gov studies registered between 2000 and 2025 that involve AI, machine learning, or digital-health tools, enriched with 30 LLM-derived variables covering use case, therapeutic area, sponsor composition, trial phase, deployment score, evidence strength, and responsible-AI keyword indicators.
Anonymized, time-series clinical records drawn from specialty provider networks and broader U.S. healthcare delivery organizations.
View source information and access options.
Archive of past performance ratings and related documentation for every skilled nursing facility.
Provider-submitted clinical performance measures consolidated into outcomes-focused datasets.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
View source information and access options.
Data for the COVID-19 clinical trials registered in the US
A structured compilation of 29,633 completed Phase 3 clinical trials sourced from ClinicalTrials.gov, including status and design details for each study record.
42,000 trials · 17 columns · binary success target · calibrated to Wong, Siah
View source information and access options.
Projected procedure volumes paired with market-share metrics across hospital service lines.
A neurology-focused clinical dataset containing detailed patient information intended to support both medical treatment and scientific investigation.
Normalized ClinicalTrials.gov records accessible within Snowflake for analytics and Cortex AI-powered applications.
Government-released health insurance records covering Part D, Medicare Advantage, and marketplace plans.
Records from the National Plan and Provider Enumeration System and the Provider Enrollment, Chain and Ownership System are combined in this dataset.
A carefully assembled and contextualized feed of essential pharmaceutical intelligence.
An almost complete listing of US clinical trial researchers, the trials they have contributed to, and their performance metrics.
Tracks FDAAA Section 801 reporting adherence, ranks sponsor credibility, and surfaces trial-level risk signals.
Pharmacovigilance risk assessment scores tied to biological mechanisms, derived from FDA prescribing information, published research, and ongoing clinical studies.
Extensive United States pharmaceutical reference data is available to support regulatory, clinical safety, and research workflows.
Analyzing the Impact of the Pandemic on Low-Income Populations